OK, TFN - name ONE SINGLE INSTITUTIONAL LENDER that offers CONVENTIONAL (not death spiral) funding to an OTC issue? But I can name you 3 dozen Institutional lenders that invest in small cap NASDAQ stocks, under conventional equity and PIPE terms, especially in the medical device/healthcare NON-bio tech market.
ALL "institutional lenders" at this level ONLY play the DEATH SPIRAL game. Thats why they call this the cesspool.
Get existing products in more retail outlets, Launch new products, and 2 or 3 for one forward split . Just a matter of time in my opinion. Some people don’t agree, thats fine but I think the stocks needs it for liquidity.